AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. CME
  4. [Form 4] CME Group Inc. Insider Trading Activity

[Form 4] CME Group Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

CME Group director Bryan T. Durkin reported the acquisition of 532 shares of Class A Common Stock on June 25, 2025 at a price of $273.03 per share. The shares were granted pursuant to the CME Group Director Stock Plan.

Following this transaction, Durkin now beneficially owns 47,207 shares directly. The filing indicates this was a standard director compensation grant rather than an open market purchase.

Key Transaction Details:

  • Transaction Type: Stock Award (Code A)
  • Ownership Type: Direct
  • Role: Director
  • Total Value of Transaction: $145,251.96

Il direttore di CME Group, Bryan T. Durkin, ha comunicato l'acquisto di 532 azioni di Classe A Common Stock il 25 giugno 2025 al prezzo di $273,03 per azione. Le azioni sono state assegnate in base al Piano Azionario per i Direttori di CME Group.

In seguito a questa operazione, Durkin possiede ora direttamente in modo beneficiario 47.207 azioni. La comunicazione specifica che si 猫 trattato di un'assegnazione standard di compenso per direttori e non di un acquisto sul mercato aperto.

Dettagli principali della transazione:

  • Tipo di transazione: Assegnazione azioni (Codice A)
  • Tipo di propriet脿: Diretta
  • Ruolo: Direttore
  • Valore totale della transazione: $145.251,96

El director de CME Group, Bryan T. Durkin, inform贸 la adquisici贸n de 532 acciones de Clase A Common Stock el 25 de junio de 2025 a un precio de $273.03 por acci贸n. Las acciones fueron otorgadas conforme al Plan de Acciones para Directores de CME Group.

Tras esta transacci贸n, Durkin posee ahora directamente y de forma beneficiaria 47,207 acciones. El informe indica que se trat贸 de una concesi贸n est谩ndar de compensaci贸n para directores y no de una compra en el mercado abierto.

Detalles clave de la transacci贸n:

  • Tipo de transacci贸n: Premio en acciones (C贸digo A)
  • Tipo de propiedad: Directa
  • Rol: Director
  • Valor total de la transacci贸n: $145,251.96

CME 攴鸽９ 鞚挫偓 Bryan T. Durkin鞚赌 2025雲� 6鞗� 25鞚�鞐� 欤茧嫻 $273.03鞚� 臧�瓴╈溂搿� 532欤�鞚� 韥措灅鞀� A 氤错喌欤茧ゼ 旆摑頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 鞚� 欤检嫕鞚赌 CME 攴鸽９ 鞚挫偓 欤检嫕 瓿勴殟鞐� 霐半澕 攵�鞐悩鞐堨姷雼堧嫟.

鞚措矆 瓯半灅 頉� Durkin鞚赌 順勳灛 歆侅爲鞝侅溂搿� 47,207欤�毳� 鞁れ鞝侅溂搿� 氤挫湢頃橁碃 鞛堨姷雼堧嫟. 鞝滌稖 靹滊鞐� 霐半ゴ氅� 鞚措姅 瓿店皽 鞁滌灔鞐愳劀鞚� 甑Г臧� 鞎勲媽 響滌 鞚挫偓 氤挫儊 攵�鞐榾鞀惦媹雼�.

欤检殧 瓯半灅 靹鸽秬靷暛:

  • 瓯半灅 鞙犿槙: 欤检嫕 氤挫儊 (旖旊摐 A)
  • 靻岇湢 鞙犿槙: 歆侅爲 氤挫湢
  • 歆侅眳: 鞚挫偓
  • 瓯半灅 齑濎暋: $145,251.96

Le directeur de CME Group, Bryan T. Durkin, a d茅clar茅 l'acquisition de 532 actions de Classe A Common Stock le 25 juin 2025 au prix de 273,03 $ par action. Les actions ont 茅t茅 attribu茅es conform茅ment au Plan d'Actions pour les Directeurs de CME Group.

脌 la suite de cette transaction, Durkin d茅tient d茅sormais directement et de mani猫re b茅n茅ficiaire 47 207 actions. Le d茅p么t indique qu'il s'agissait d'une attribution standard de r茅mun茅ration pour directeur et non d'un achat sur le march茅 libre.

D茅tails cl茅s de la transaction :

  • Type de transaction : Attribution d'actions (Code A)
  • Type de propri茅t茅 : Directe
  • R么le : Directeur
  • Valeur totale de la transaction : 145 251,96 $

Der Direktor von CME Group, Bryan T. Durkin, meldete den Erwerb von 532 Aktien der Klasse A Stammaktien am 25. Juni 2025 zu einem Preis von $273,03 pro Aktie. Die Aktien wurden gem盲脽 dem CME Group Director Stock Plan gew盲hrt.

Nach dieser Transaktion besitzt Durkin nun direkt wirtschaftlich 47.207 Aktien. Die Meldung weist darauf hin, dass es sich um eine Standardverg眉tung f眉r Direktoren handelte und nicht um einen Kauf am offenen Markt.

Wichtige Transaktionsdetails:

  • Transaktionstyp: Aktienzuteilung (Code A)
  • Besitzart: Direkt
  • Rolle: Direktor
  • Gesamtwert der Transaktion: $145.251,96
Positive
  • None.
Negative
  • None.

Il direttore di CME Group, Bryan T. Durkin, ha comunicato l'acquisto di 532 azioni di Classe A Common Stock il 25 giugno 2025 al prezzo di $273,03 per azione. Le azioni sono state assegnate in base al Piano Azionario per i Direttori di CME Group.

In seguito a questa operazione, Durkin possiede ora direttamente in modo beneficiario 47.207 azioni. La comunicazione specifica che si 猫 trattato di un'assegnazione standard di compenso per direttori e non di un acquisto sul mercato aperto.

Dettagli principali della transazione:

  • Tipo di transazione: Assegnazione azioni (Codice A)
  • Tipo di propriet脿: Diretta
  • Ruolo: Direttore
  • Valore totale della transazione: $145.251,96

El director de CME Group, Bryan T. Durkin, inform贸 la adquisici贸n de 532 acciones de Clase A Common Stock el 25 de junio de 2025 a un precio de $273.03 por acci贸n. Las acciones fueron otorgadas conforme al Plan de Acciones para Directores de CME Group.

Tras esta transacci贸n, Durkin posee ahora directamente y de forma beneficiaria 47,207 acciones. El informe indica que se trat贸 de una concesi贸n est谩ndar de compensaci贸n para directores y no de una compra en el mercado abierto.

Detalles clave de la transacci贸n:

  • Tipo de transacci贸n: Premio en acciones (C贸digo A)
  • Tipo de propiedad: Directa
  • Rol: Director
  • Valor total de la transacci贸n: $145,251.96

CME 攴鸽９ 鞚挫偓 Bryan T. Durkin鞚赌 2025雲� 6鞗� 25鞚�鞐� 欤茧嫻 $273.03鞚� 臧�瓴╈溂搿� 532欤�鞚� 韥措灅鞀� A 氤错喌欤茧ゼ 旆摑頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 鞚� 欤检嫕鞚赌 CME 攴鸽９ 鞚挫偓 欤检嫕 瓿勴殟鞐� 霐半澕 攵�鞐悩鞐堨姷雼堧嫟.

鞚措矆 瓯半灅 頉� Durkin鞚赌 順勳灛 歆侅爲鞝侅溂搿� 47,207欤�毳� 鞁れ鞝侅溂搿� 氤挫湢頃橁碃 鞛堨姷雼堧嫟. 鞝滌稖 靹滊鞐� 霐半ゴ氅� 鞚措姅 瓿店皽 鞁滌灔鞐愳劀鞚� 甑Г臧� 鞎勲媽 響滌 鞚挫偓 氤挫儊 攵�鞐榾鞀惦媹雼�.

欤检殧 瓯半灅 靹鸽秬靷暛:

  • 瓯半灅 鞙犿槙: 欤检嫕 氤挫儊 (旖旊摐 A)
  • 靻岇湢 鞙犿槙: 歆侅爲 氤挫湢
  • 歆侅眳: 鞚挫偓
  • 瓯半灅 齑濎暋: $145,251.96

Le directeur de CME Group, Bryan T. Durkin, a d茅clar茅 l'acquisition de 532 actions de Classe A Common Stock le 25 juin 2025 au prix de 273,03 $ par action. Les actions ont 茅t茅 attribu茅es conform茅ment au Plan d'Actions pour les Directeurs de CME Group.

脌 la suite de cette transaction, Durkin d茅tient d茅sormais directement et de mani猫re b茅n茅ficiaire 47 207 actions. Le d茅p么t indique qu'il s'agissait d'une attribution standard de r茅mun茅ration pour directeur et non d'un achat sur le march茅 libre.

D茅tails cl茅s de la transaction :

  • Type de transaction : Attribution d'actions (Code A)
  • Type de propri茅t茅 : Directe
  • R么le : Directeur
  • Valeur totale de la transaction : 145 251,96 $

Der Direktor von CME Group, Bryan T. Durkin, meldete den Erwerb von 532 Aktien der Klasse A Stammaktien am 25. Juni 2025 zu einem Preis von $273,03 pro Aktie. Die Aktien wurden gem盲脽 dem CME Group Director Stock Plan gew盲hrt.

Nach dieser Transaktion besitzt Durkin nun direkt wirtschaftlich 47.207 Aktien. Die Meldung weist darauf hin, dass es sich um eine Standardverg眉tung f眉r Direktoren handelte und nicht um einen Kauf am offenen Markt.

Wichtige Transaktionsdetails:

  • Transaktionstyp: Aktienzuteilung (Code A)
  • Besitzart: Direkt
  • Rolle: Direktor
  • Gesamtwert der Transaktion: $145.251,96
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Durkin Bryan T
(Last) (First) (Middle)
20 S. WACKER DRIVE
(Street)
CHICAGO IL 60606
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CME GROUP INC. [ CME ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock Class A 06/25/2025 A(1) 532 A $273.03 47,207 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Granted pursuant to the CME Group Director Stock Plan, as amended and restated.
Remarks:
By: Jenelle Chalmers For: Bryan T. Durkin 06/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

How many CME Group shares did Director Bryan Durkin acquire on June 25, 2025?

According to the Form 4 filing, Director Bryan T. Durkin acquired 532 shares of CME Group Class A Common Stock on June 25, 2025, at a price of $273.03 per share.

What is Bryan Durkin's total CME stock ownership after the June 2025 transaction?

Following the reported transaction, Bryan T. Durkin beneficially owned 47,207 shares of CME Group Class A Common Stock directly (Form D).

How were the CME shares granted to Director Durkin in June 2025?

The shares were granted pursuant to the CME Group Director Stock Plan, as amended and restated, as indicated in the footnotes of the Form 4 filing.

Who filed the Form 4 for CME Director Bryan Durkin?

The Form 4 was filed by Jenelle Chalmers on behalf of Bryan T. Durkin on June 26, 2025, one day after the transaction date.

What is Bryan Durkin's role at CME Group according to the Form 4?

According to the Form 4 filing, Bryan T. Durkin serves as a Director of CME Group Inc., as indicated by the 'X' marked in the Director box under the relationship to issuer section.
Stock CME logo
CME Group

NASDAQ:CME

CME Rankings

#183 Ranked by Market Cap
#1470 Ranked by Dividends

CME Latest News

Jul 23, 2025
CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q2 2025
Jul 22, 2025
CME Group and Nasdaq Extend Exclusive Nasdaq-100 Futures License Through 2039
Jul 10, 2025
CME Group International Average Daily Volume Hits Record 9.2 Million Contracts in Q2 2025, Up 18% Year over Year
Jul 2, 2025
CME Group Completes First Delivery Cycle of Hard Red Spring Wheat Futures
Jul 2, 2025
CME Group Sets Record Quarterly and June ADV, Driven by Growth Across Asset Classes

CME Latest SEC Filings

Jul 25, 2025
[8-K] CME Group Inc. Reports Material Event
Jul 23, 2025
[8-K] CME Group Inc. Reports Material Event
Jun 26, 2025
[Form 4] CME Group Inc. Insider Trading Activity
Jun 26, 2025
[Form 4] CME Group Inc. Insider Trading Activity
Jun 26, 2025
[Form 4] CME Group Inc. Insider Trading Activity

CME Stock Data

99.63B
358.67M
0.46%
89.89%
1.4%
Financial Data & Stock Exchanges
Security & Commodity Brokers, Dealers, Exchanges & Services
United States
CHICAGO